Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 42
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Prospects for γ-ray observations of the Perseus galaxy cluster with the Cherenkov Telescope Array

  • Alvarez-Crespo, N.
  • Barrio Uña, Juan Abel
  • Contreras González, José Luis
  • Láinez, M.
  • López Moya, Marcos
  • Martinez, O.
  • Mas-Aguilar, A.
  • Miener, Tjark
  • Miranda, J.M.
  • Morcuende Parrilla, Daniel
  • Nieto Castaño, Daniel
  • Rosado Vélez, Jaime
  • Sinha, Atreyee
  • Tejedor Álvarez, Luis Ángel
  • Zamanillo, V.M.
Galaxy clusters are expected to be both dark matter (DM) reservoirs and storage rooms for the cosmic-ray protons (CRp) that accumulate along the cluster’s formation history. Accordingly, they are excellent targets to search for signals of DM annihilation and decay at γ-ray energies and are predicted to be sources of large-scale γ-ray emission due to hadronic interactions in the intracluster medium (ICM). In this paper, we estimate the sensitivity of the Cherenkov Telescope Array (CTA) to detect diffuse γ-ray emission from the Perseus galaxy cluster. We first perform a detailed spatial and spectral modelling of the expected signal for both the DM and the CRp components. For each case, we compute the expected CTA sensitivity accounting for the CTA instrument response functions. The CTA observing strategy of the Perseus cluster is also discussed. In the absence of a diffuse signal (non-detection), CTA should constrain the CRp to thermal energy ratio X500 within the characteristic radius R500 down to about X500 < 3 × 10−3, for a spatial CRp distribution that follows the thermal gas and a CRp spectral index αCRp = 2.3. Under the optimistic assumption of a pure hadronic origin of the Perseus radio mini-halo and depending on the assumed magnetic field profile, CTA should measure αCRp down to about ∆αCRp ≃ 0.1 and the CRp spatial distribution with 10% precision, respectively. Regarding DM, CTA should improve the current ground-based γ-ray DM limits from clusters observations on the velocity-averaged annihilation cross-section by a factor of up to ∼ 5, depending on the modelling of DM halo substructure. In the case of decay of DM particles, CTA will explore a new region of the parameter space, reaching models with τχ > 1027 s for DM masses above 1 TeV. These constraints will provide unprecedented sensitivity to the physics of both CRp acceleration and transport at cluster scale and to TeV DM particle models, especially in the decay scenario.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Role of Antigen Carbohydrate 125 in Modulating Soluble ST2, Prognostic-Related Effects in Acute Heart Failure

  • Martí-Martínez, Arancha
  • Núñez, Julio|||0000-0003-1672-7119
  • López Escribano, Herminio
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Mollar, Anna
  • Peiró, Marta
  • Sanchis, Juan|||0000-0003-0797-8709
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Carratala, Arturo|||0000-0003-4513-7214
  • Miró, Oscar|||0000-0002-7924-9751
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
Background: Acute heart failure (AHF) is a complex syndrome associated with high mortality and hospital readmissions, characterized by volume overload and inflammation. Soluble ST2 (sST2) and antigen carbohydrate 125 (CA125) are emerging biomarkers that reflect these processes and may interact to influence long-term outcomes in AHF patients. This study aims to examine the prognostic relationship between sST2 and CA125 in predicting mortality and heart failure (HF)-related hospitalizations in patients with decompensated heart failure. Methods: In a cohort of 635 patients with AHF, we investigated whether the prognostic value of sST2 varies according to CA125 levels (≤35 vs. >35 U/mL). The endpoints were: (a) time to all-cause death, and (b) the combination of time to death or new HF admission. Results: This study of EAHFE registry data shows that the association between sST2 and long-term adverse outcomes (mortality and HF hospitalizations) in patients with AHF was differentially influenced by CA125 concentrations (p-value for interactions = 0.031 and 0.029, respectively). Higher sST2 was associated with the risk of death and the combined risk of death/HF readmission when CA125 was >35 U/mL [HR = 1.02 (CI 95%: 1.01-1.04), p = 0.006 and 1.02 (CI 95%: 1.01-1.03); p = 0.013 per increase in 10 ng/mL, respectively], but not when CA125 was ≤35 U/mL. Conclusions: This study highlights the prognostic interaction between sST2 and CA125 in AHF. Elevated sST2 predicts poor outcomes mainly in patients with high CA125 levels (>35 U/mL), suggesting CA125's role in modulating inflammatory activity in HF. Further research is needed.
Repisalud
Publication Artículo científico (JournalArticle)

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

  • Restrepo, Clara
  • Gutiirrez-Rivas, Monica
  • Pacheco, Yolanda María
  • García, Marcial
  • Blanco, Julià
  • Medrano, Luz Maria
  • Navarrete-Muñoz, María A
  • Gutiérrez, Félix
  • Miralles, Pilar
  • Dalmau, David
  • Gómez, Juan Luis
  • Górgolas, Miguel
  • Cabello, Alfonso
  • Resino, Salvador
  • Benito, José Miguel
  • Rallón, Norma
OBJECTIVE: We investigated the association of genetic polymorphisms in chemokine and chemokine receptor genes with poor immunological recovery in HIV patients starting combined antiretroviral therapy (cART) with low CD4 T-cell counts. METHODS: A case-control study was conducted in 412 HIV-infected patients starting cART with CD4 T-cell count <200 cells/μL and successful viral control for two years. CD4 count increase below 200 cells/μL after two years on cART was used to define INR (immunological non-responder) patients. Polymorphisms in CXCL12, CCL5 and CCR2 genes were genotyped using sequenom's MassARRAY platform. RESULTS: Thirty two percent (134/412) of patients were classified as INR. After adjusting by age, route of HIV infection, length of infection before cART and viral hepatitis coinfection, CCR2 rs1799864-AG genotype was significantly associated with INR status (OR [95% CI]: 1.80 [1.04-3.11]; p = 0.04), and CXCL12 rs1801157-TT genotype showed a trend (OR [95% CI]: 2.47 [0.96-6.35]; p = 0.06). CONCLUSIONS: CCR2 rs1799864-AG or CXCL12 rs1801157-TT genotypes influence on the probability of poor CD4 recovery in the population of HIV patients starting cART with low CD4 counts. Genotyping of these polymorphisms could be used to estimate the risk of poor CD4 restoration, mainly in patients who are diagnosed late in the course of infection.
Repisalud
Publication Artículo científico (JournalArticle)

Mammographic density and breast cancer in women from high risk families

  • Ramón Y Cajal, Teresa
  • Chirivella, Isabel
  • Miranda, Josefa
  • Teule, Alexandre
  • Izquierdo, Angel
  • Balmaña, Judith
  • Sánchez-Heras, Ana Beatriz
  • Llort, Gemma
  • Fisas, David
  • Lope Carvajal, Virginia
  • Hernandez-Agudo, Elena
  • Juan-Fita, María José
  • Tena, Isabel
  • Robles, Luis
  • Guillén-Ponce, Carmen
  • Pérez-Segura, Pedro
  • Luque-Molina, Mari Sol
  • Hernando-Polo, Susana
  • Salinas, Mónica
  • Brunet, Joan
  • Salas-Trejo, Dolores
  • Barnadas, Agustí
  • Pollan-Santamaria, Marina
INTRODUCTION: Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype. METHODS: The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling Units. Participants' density was scored retrospectively from available mammograms by a single blinded radiologist using a 5-category scale (<10 %, 10-25 %, 25-50 %, 50-75 %, >75 %). In BC cases, we selected mammograms taken prior to diagnosis or from the contralateral breast, whereas, in non-cases, the last screening mammogram was evaluated. MD distribution in carriers and non-carriers was compared using ordinal logistic models, and the association between MD and BC in BRCA1/2 mutation carriers was studied using logistic regression. Huber-White robust estimators of variance were used to take into account correlations between family members. A similar multinomial model was used to explore this association by BC subtype. RESULTS: We identified and scored mammograms from 341 BRCA1, 350 BRCA2 mutation carriers and 229 non-carriers. Compared to non-carriers, MD was significantly lower among BRCA2 mutation carriers (odds ratio (OR) =0.71; P-value=0.04), but not among BRCA1 carriers (OR=0.84; P-value=0.33). MD was associated with subsequent development BC (OR per category of MD=1.45; 95 % confidence interval=1.18-1.78, P-value<0.001), with no significant differences between BRCA1 and BRCA2 mutation carriers (P-value=0.48). Finally, no statistically significant differences were observed in the association of MD with specific BC subtypes. CONCLUSIONS: Our study, the largest to date on this issue, confirms that MD is an independent risk factor for all BC subtypes in either BRCA1 and BRCA2 mutation carriers, and should be considered a phenotype risk marker in this context.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure

  • Mollar, Anna
  • Garcia-Conejo, Celia
  • Revuelta-Lopez, Elena
  • Cardells, Ingrid
  • Lopez, Raquel
  • Canto Serrano, Irene Del
  • de la Espriella, Rafael
  • Lopez-Lereu, Maria P.
  • Monmeneu, Jose Vicente
  • Maceira, Alicia
  • Lakhal-Littleton, Samira
  • Almenar, Luis
  • Cases, Aleix
  • Peiro, Marta
  • Bayes Genis, Antonio
[EN] Iron deficiency (ID) treated with ferric carboxymaltose (FCM) previously showed reduced platelet count; however, no studies have evaluated its biological significance in heart failure. In the current study, we aimed to: (a) assess the changes in platelet count at 7 and 30 days post-FCM, and (b) explore its association with non-invasive surrogates of myocardial iron uptake and left systolic function in patients with ID and heart failure with left ventricular ejection fraction < 50% (HFrEF and HFmrEF). This post-hoc analysis of a randomized, double-blind, FCM vs. placebo clinical trial (Myocardial-IRON Trail) involved 45 outpatients with HFrEF and HFmrEF and ID in which the platelet count value was available. Platelet count, cardiac magnetic resonance T1-mapping and 3D-global longitudinal strain (CMR-GLS) were assessed at baseline, 7, and 30 days. Linear regression models were used to evaluate the between-treatment differences and endpoints. The mean (SD) age was 71 +/- 8 years, and 32 (71%) were men. At 30 days, we found a significant reduction in platelet count in those treated with FCM (p-value = 0.027). In those treated with FCM, the greater 30-day decrease in platelets showed lower 30-day changes in T1-mapping (p = 0.024) and CMR-GLS (p = 0.028). After administration of FCM, we found a significant 30-day reduction in platelet count. The greater platelet count reduction was related to lower myocardial iron repletion and a smaller improvement in left ventricular systolic function., This work was supported in part by an unrestricted grant from Vifor Pharma, CIBER Cardiovascular [grant numbers 16/11/00420 and 16/11/00403], Unidad de Investigacion Clinica y Ensayos Clinicos INCLIVA Health Research Institute, Spanish Clinical Research Network (SCReN; PT13/0002/0031 and PT17/0017/0003), cofounded by Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III, and Proyectos de Investigacion de la Seccion de Insuficiencia Cardiaca 2017 from the Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Uplifting edges in higher-order networks: Spectral centralities for non-uniform hypergraphs

  • Contreras-Aso, Gonzalo
  • Romance, Miguel
  • Pérez-Corral, Cristian|||0009-0006-4616-1960
[EN] Spectral analysis of networks states that many structural properties of graphs, such as the centrality of their nodes, are given in terms of their adjacency matrices. The natural extension of such spectral analysis to higher-order networks is strongly limited by the fact that a given hypergraph could have several different adjacency hypermatrices, and hence the results obtained so far are mainly restricted to the class of uniform hypergraphs, which leaves many real systems unattended. A new method for analyzing non-linear eigenvector-like centrality measures of non-uniform hypergraphs was presented in this paper that could be useful for studying properties of H-eigenvectors and Z- eigenvectors in the non-uniform case. In order to do so, a new operation-the uplift-was introduced, incorporating auxiliary nodes in the hypergraph to allow for a uniform-like analysis. We later argued why this was a mathematically sound operation, and we furthermore used it to classify a whole family of hypergraphs with unique Perron-like Z-eigenvectors. We supplemented the theoretical analysis with several examples and numerical simulations on synthetic and real datasets: On the latter, we find a clear improvement over the existing methods, specially in cases where there is a huge disparity between the structure at each order, and on the former, we find that regardless of the chosen uniformization scheme, the nodes were similarly ranked., This work has been partially supported by INCIBE/URJC Agreement M3386/2024/0031/001 within the framework of the Recovery, Transformation and Resilience Plan funds of the European Union (Next Generation EU) and by projects M2978 and M3033 (URJC Grants) . G. C -A acknowledges funding from the URJC fellowship PREDOC-21-026-2164.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Synthesis, crystal structure, thermal and magnetic properties of [Mn(H2O)6][Cu(pdta).2H2O (pdta= 1,3-propylenediamine-N,N,N&apos, ,N&apos, -tetraacetate

  • Hernández-Padilla, M.
  • Chinea, E.
  • Domínguez, S.
  • Mederos, A.
  • Lloret, F.
  • Muñoz Roca, María Del Carmen|||0000-0003-2630-3897
[EN] On mixing concentrated aqueous solutions of pdta, Cu(II) and Mn(II) in the ratio 1:1:1 at pH 4.5, single crystals of the complex [Mn(H2O)6][Cu(pdta)]·2H2O (1) (pdta=1,3-propylenediamine-N,N,N'N'-tetraacetate) were obtained. X-ray structural analysis revealed that in the anion [Cu(pdta)]2- the coordination polyhedron around the Cu(II) ion can be described as a tetragonaly distorted CuN2O4 octahedron, whereas the cation [Mn(H2O)6]2+ can be described as a very regular MnO6 octahedron. Thermogravimetric analysis shows that at 110°C compound 1 loses its eight water molecules yielding the anhydrous compound [MnCu(pdta)] (2). Variable-temperature magnetic susceptibility measurements indicate that no magnetic interactions are present in 1 while weak antiferromagnetic interactions occur in 2., This work was partially supported by the CICYT (Spain) through Projects PB97-1397 (Valencia) and APC94-0031 (La Laguna). Instrumental and computing facilities of the Servicio de Espectroscop&#305;&#769;a y Centro de Cálculo de la Universitat de València are gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Search for Spatial Correlations of Neutrinos with Ultra-high-energy Cosmic Rays

  • Albert, A.
  • Alves, S.
  • Andre, M.
  • Anghinolfi, M.
  • Aubert,, J.J.
  • Aublin, J.
  • Baret, B.
  • Basa, S.
  • Belhorma, B.
  • Bendahman, M.
  • Bertin, V.
  • Biagi, S.
  • M. Bissinger
  • Martínez Mora, Juan Antonio
  • Poirè, Chiara
  • Ardid, Miguel|||0000-0002-3199-594X
  • Ardid, S.|||0000-0003-4821-6655
[EN] For several decades, the origin of ultra-high-energy cosmic rays (UHECRs) has been an unsolved question of high- energy astrophysics. One approach for solving this puzzle is to correlate UHECRs with high-energy neutrinos, since neutrinos are a direct probe of hadronic interactions of cosmic rays and are not de¿ected by magnetic ¿elds. In this paper, we present three different approaches for correlating the arrival directions of neutrinos with the arrival directions of UHECRs. The neutrino data are provided by the IceCube Neutrino Observatory and ANTARES, while the UHECR data with energies above ~50 EeV are provided by the Pierre Auger Observatory and the Telescope Array. All experiments provide increased statistics and improved reconstructions with respect to our previous results reported in 2015. The ¿rst analysis uses a high-statistics neutrino sample optimized for point- source searches to search for excesses of neutrino clustering in the vicinity of UHECR directions. The second analysis searches for an excess of UHECRs in the direction of the highest-energy neutrinos. The third analysis searches for an excess of pairs of UHECRs and highest-energy neutrinos on different angular scales. None of the analyses have found a signi¿cant excess, and previously reported over¿uctuations are reduced in signi¿cance. Based on these results, we further constrain the neutrino ¿ux spatially correlated with UHECRs., The authors of the ANTARES collaboration acknowledge the financial support of the funding agencies: Centre National de la Recherche Scientifique (CNRS), Commissariat a l'energie atomique et aux energies alternatives (CEA), Commission Europeenne (FEDER fund and Marie Curie Program), Institut Universitaire de France (IUF), LabEx UnivEarthS (ANR-10-LABX-0023 and ANR-18-IDEX-0001), Region Ile-de-France (DIM-ACAV), Region Alsace (contrat CPER), Region Provence-Alpes-Cote d'Azur, Departement du Var and Ville de La Seyne-sur-Mer, France; Bundesministerium fur Bildung und Forschung (BMBF), Germany; Istituto Nazionale di Fisica Nucleare (INFN), Italy; Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO), the Netherlands; Council of the President of the Russian Federation for young scientists and leading scientific schools supporting grants, Russia; Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI), Romania; Ministerio de Ciencia, Innovacion, Investigacion y Universidades (MCIU): Programa Estatal de Generacion de Conocimiento (refs. PGC2018-096663-B-C41, -A-C42, -B-C43, -B-C44) (MCIU/FEDER), Generalitat Valenciana: Prometeo (PROMETEO/2020/019), Grisolia (refs. GRISOLIA/2018/119,/2021/192) and GenT (refs. CIDEGENT/2018/034,/2019/043,/2020/049,/2021/023) programs, Junta de Andalucia (ref. A-FQM-053-UGR18), La Caixa Foundation (ref. LCF/BQ/IN17/11620019), EU: MSC program (ref. 101025085), Spain; Ministry of Higher Education, Scientific Research and Innovation, Morocco, and the Arab Fund for Economic and Social Development, Kuwait. We also acknowledge the technical support of Ifremer, AIM and Foselev Marine for the sea operation and the CC-IN2P3 for the computing facilities. The ANTARES collaboration acknowledges the significant contributions to this manuscript from Julien Aublin.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Characterization of Maya Blue Pigment in Pre-Classic and Classic Monumental Architecture of the Ancient Pre-Culombian City of Calakmul (Campeche, Mexico)

  • Vázquez de Agredos Pascual, María Luisa
  • Domenech Carbo, Antonio
  • Domenech Carbo, Mª Teresa|||0000-0003-3660-2161
This paper presents the first evidence of the use of Maya Blue pigment in late pre-classic (c.300BC-300AD) architecture in the Maya Lowlands. This was detected combining an innovative technique, the voltammetry of microparticles (VMP), with atomic force microscopy (AFM), transmission electron microscopy (TEM), scanning electron microscopy/energy dispersive X-ray microanalysis (SEM/EDX), visible spectrophotometry and Fourier transform infrared spectroscopy (FTIR). The pigment was found on the polychrome facade of substructure IIC of pre-Columbian city of Calakmul (Campeche, Mexico). The identification of Maya Blue in this building may prove to be the earliest known use of this colour on the monumental architecture of the Maya Lowlands. The colour was seen to precede the Maya Blue pigments identified in other archaeological sites and dated from later periods and this, together with the analytical results recently obtained in the early classic (c.300AD-600AD) and the late classic (c.600AD-850/900AD) wall paintings of Calakmul, reveal the technical development of this complex pigment in Maya wall painting throughout classic and post-classic periods. © 2010., We are grateful to the Instituto Nacional de Antropologia e Historia of Mexico (INAH) for permitting the exploration of samples, and especially to the Archaeologist Ramon Carrasco Vargas, current Director of "Calakmul Project". Wegratefully acknowledge the financial backing from the Spanish "I + D + I MEC" project CTQ2008-06727-C03-01/BQU and 02/BQU, and the Generalitat Valenciana "I + D + I" projects GV04B/197 and ACOMP/2007/138, which are also supported by ERDEF funds as well as the SB2005-0031 project ascribed to the program of postdoctoral stages of novel researchers in Spanish universities and research centres from the Ministerio de Educacion y Ciencia (MEC).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial

  • del Canto Serrano, Irene
  • Santas, Enrique
  • Cardells, Ingrid
  • Miñana, Gema
  • Palau, Patricia
  • Llàcer, Pau
  • Fácila, Lorenzo
  • López-Vilella, Raquel
  • Almenar, Luis
  • Bodí, Vicent
  • López-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Sanchis, Juan
  • Maceira, Alicia M.
  • Moratal, David|||0000-0002-2825-3646
[EN] BACKGROUND: The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial-IRON trial showed short-term cardiac magnetic resonance (CMR) changes suggesting myocardial iron repletion following administration of FCM but failed to find a significant increase in left ventricular ejection fraction in the whole sample. Conversely, the strain assessment could evaluate more specifically subtle changes in contractility. In this subanalysis, we aimed to evaluate the effect of FCM on the short-term left and right ventricular CMR feature tracking derived strain. METHODS AND RESULTS: This is a post hoc subanalysis of the double-blind, placebo-controlled, randomized clinical trial that enrolled 53 ambulatory patients with heart failure and left ventricular ejection fraction <50%, and iron deficiency [Myocardial-IRON trial (NCT03398681)]. Three-dimensional left and 2-dimensional right ventricular CMR tracking strain (longitudinal, circumferential, and radial) changes were evaluated before, 7 and 30 days after randomization using linear mixed-effect analysis. The median (interquartile range) age of the sample was 73 years (65-78), and 40 (75.5%) were men. At baseline, there were no significant differences in CMR feature tracking strain parameters across both treatment arms. At 7 days, the only global 3-dimensional left ventricular circumferential strain was significantly higher in the FCM treatment-arm (difference: -1.6%, P=0.001). At 30 days, and compared with placebo, global 3-dimensional left ventricular strain parameters significantly improved in those allocated to FCM treatment-arm [longitudinal (difference: -2.3%, P<0.001), circumferential (difference: -2.5%, P<0.001), and radial (difference: 4.2%, P=0.002)]. Likewise, significant improvements in global right ventricular strain parameters were found in the active arm at 30 days (longitudinal [difference: -3.3%, P=0.010], circumferential [difference: -4.5%, P<0.001], and radial [difference: 4.5%, P=0.027]). CONCLUSIONS: In patients with stable heart failure, left ventricular ejection fraction <50%, and iron deficiency, treatment with FCM was associated with short-term improvements in left and right ventricular function assessed by CMR feature tracking derived strain parameters., This work was supported in part by an unrestricted grant from Vifor Pharma, CIBER Cardiovascular [grant numbers 16/11/00420 and 16/11/00403], Unidad de Investigacion Clinica y Ensayos Clinicos INCLIVA Health Research Institute, Spanish Clinical Research Network (SCReN; PT13/0002/0031 and PT17/0017/0003), cofounded by Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III, and Proyectos de Investigacion de la Seccion de Insuficiencia Cardiaca 2017 from Sociedad Espanola de Cardiologia.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Unraveling the potential of hypothalamic deep brain stimulation for obesity: Impacts on memory, neuroplasticity and brain metabolism in the Zucker rat

  • Casquero-Veiga, Marta
  • Llorca Torralba, Meritxell
  • Bueno-Fernandez, C.
  • Romero-Miguel, Diego
  • Lamanna-Rama, Nicolás
  • Winter, C.
  • Berrocoso Domínguez, Esther María
  • Nacher, Juan
  • Desco, Manuel
  • Soto-Montenegro, María Luisa
The lateral hypothalamus (LH) plays a key role in regulating energy balance and appetite, making it a potential target for deep brain stimulation (DBS) in treatment-resistant obesity. In this study, we evaluated the short and long-term in vivo effects of continuous LH-DBS over 15 days in a genetic model of obesity: the Zucker rat. We examined changes in body weight, brain glucose metabolism (via positron emission tomography, PET), and memory performance, along with ex vivo neuroplasticity in different hippocampal layers one month post-treatment. Contrary to expectations, continuous LH-DBS did not reduce the weight gain or food intake. While stimulated rats exhibited hippocampal hypermetabolism and enhanced synaptogenesis, these changes did not translate into cognitive improvements. Interestingly, long-term memory benefits were observed in all animals that underwent surgery, regardless of whether they received stimulation. In conclusion, our results do not support continuous LH-DBS as an effective treatment to reduce body weight in cases of obesity with genetic leptin resistance. However, the hippocampal modulation induced by continuous LH-DBS shows potential for addressing cognitive impairments associated with leptin resistance. These findings suggest that alternative DBS protocols may help restore hippocampal function, warranting further investigation.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Fibroblast Growth Factor 23 and Outcomes in Acute Heart Failure

  • Martí-Martínez, Arancha
  • Nuñez, Julio
  • López-Escribano, Herminio
  • de la Espriella, Rafael
  • Santas, Enrique
  • Rodríguez Borja, Enrique
  • Miró, Òscar
  • Llorens, Pere
  • Alquézar-Arbé, Aitor
  • Herrero-Puente, Pablo
  • Llorens, Pere|||/items/757956aa-c39c-4e15-850b-e5bf9ed72f94
Worsening heart failure (WHF) is a complex clinical syndrome associated with a high risk of mortality and further decompensations, characterized by fluid overload and upregulated inflammatory and fibrotic processes linked to organ dysfunction. Fibroblast growth factor 23 (FGF23) is an emerging proxy of fibrosis and may interact to influence long-term outcomes in WHF patients. This study evaluated the association between FGF23 levels and long-term outcomes in patients with WHF evaluated in the emergency department (ED). A total of 635 patients from the EAHFE registry, enrolled during 2007, 2009, and 2011, were prospectively included. FGF23 was measured in the first blood sample obtained at ED presentation. During a median follow-up of 380 days (interquartile range: 126 to 456), all-cause mortality occurred in 216 patients (34.0%), while 351 patients (55.3%) experienced the composite endpoint of death/WHF ED reconsultation and 295 (46.5%) experienced death/HF hospitalization. Event rates increased progressively across FGF23 levels. Patients with FGF23 above the median (48.4 pg/mL) displayed higher rates (per 100 patient-years) of all-cause mortality (49 vs. 31, p = 0.003), death/WHF ED reconsultation (93 vs. 65, p = 0.003), and death/HF hospitalization (77 vs. 56, p = 0.043). In continuous analyses, each doubling of FGF23 remained significantly associated with an increased risk of all three outcomes after multivariable adjustment. These associations were consistent across clinically relevant subgroups, including those defined by age, sex, and kidney function, supporting the potential prognostic value of FGF23 within this cohort, although external validation is warranted.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Building wood debris piles benefits avian seed dispersers in burned and logged Mediterranean pine forests

  • Rost Bagudanch, Josep
  • Clavero Pineda, Miguel
  • Bas Lay, Josep M. (Josep Maria)
  • Pons Ferran, Pere
Salvage logging is a common practice carried out in burned forests worldwide, and intended to mitigate the economic losses caused by wildfires. Logging implies an additional disturbance occurring shortly after fire, although its ecological effects can be somewhat mitigated by leaving wood debris on site. The composition of the bird community and its capacity to provide ecosystem services such as seed dispersal of fleshy-fruited plants have been shown to be affected by postfire logging. We assessed the effects of the habitat structure resulting from different postfire management practices on the bird community, in three burned pine forests in Catalonia (western Mediterranean). For this purpose, we focused on the group of species that is responsible for seed dispersal, a process which takes place primarily during the winter in the Mediterranean basin. In addition, we assessed microhabitat selection by seed disperser birds in such environments in relation to management practices. Our results showed a significant, positive relationship between the density of wood debris piles and the abundance of seed disperser birds. Furthermore, such piles were the preferred microhabitat of these species. This reveals an important effect of forest management on seed disperser birds, which is likely to affect the dynamics of bird-dependent seed dispersal. Thus, building wood debris piles can be a useful practice for the conservation of both the species and their ecosystem services, while also being compatible with timber harvesting., This study was funded by the Spanish Ministry of Science and Innovation (CGL2005-0031/BOS and CGL2008-05506/BOS) and J.R. held a FPU grant of the Ministry of Education.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Discriminant analysis using fatty acids profile, stable carbon isotopes and tocopherols content as tool for feeding system prediction in Iberian pigs

  • García Casco, Juan María
  • Delgado-Chavero, C. L.
  • Zapata, Elena
  • Paredes, Andrés
  • Muñoz, María
  • Rey, Ana I.
11 Pág., Aim of study: The application of three analytical methods (fatty acids: FA, tocopherols: TOC, and isotope ratio: ISO) to distinguish the feeding type received by Iberian pigs during the fattening stage. Area of study: This distinction is very important for the labelling of Iberian high-quality products in the Quercus forest located on the southwest of Iberian Peninsula, where several production systems coexist. Material and methods: Discriminant analysis on fat samples with unknown background obtained from commercial pigs was applied. The feasibility of the combination method to determine the authentication of feeding background was studied on samples from different fattening system: free-range feeding with acorn and pastures (BE); free-range feeding acorn and pastures plus commercial feeds (RE); open-air feeding with commercial feeds (CA); standard feeding with commercial feeds (CE). Main results: In a first application of the methods, the overall success rate was 60.1% for FA, 49.7% for ISO and 49.3% for TOC. When some of the batches were reclassified attending to those previous results and additional information available about farm characteristics, ISO and TOC analyses had a 70% of success rate in the four categories, whereas FA showed 40.5%, attributable to the use of high-oleic commercial diets. The predictions improved with the method combination. The ISO+TOC combination achieved a 84.1% of success in prediction. When it was reduced to just two categories (acorn vs non-acorn), the success reached a 95% for FA+TOC and ISO+TOC. Research highlights: The use of these methods as a complementary tool for quality controls is highly recommended to avoid undesirable misclassifications., INIA, Spain (INIA-RTA2008-00026) Agreement INIA-Ministerio de Medio Ambiente, Medio Rural y Marino (CC08-0031), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?

  • Rangel-Pelaez, Carlos
  • Martínez-Gutiérrez, Laura
  • Tristán-Manzano, María
  • Callejas-Rubio, José Luis
  • Ortego-Centeno, Norberto
  • Martín, Francisco
  • Martín, Javier
Autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis, involve dysregulated immune responses causing chronic inflammation and tissue damage. Despite advancements in clinical management, many patients do not respond to current treatments, which often show limited efficacy due to the persistence of autoreactive B cells. Chimeric antigen receptor (CAR)-T cell therapy, which has shown success in oncology for B cell malignancies, targets specific antigens and involves the adoptive transfer of genetically engineered T cells. CD19 CAR-T cells, in particular, have shown promise in depleting circulating B cells and achieving clinical remission. This review discusses the potential of CD19 CAR-T cells in ARDs, highlighting clinical achievements and addressing key considerations such as optimal target cell populations, CAR construct design, acceptable toxicities, and the potential for lasting immune reset, crucial for the safe and effective adoption of CAR-T cell therapy in autoimmune treatments., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Cooperative Research Networks Oriented to Health Results (RICORS), Inflammatory Diseases Network (REI) (RD21/0002/0039; RD24/0007/0016) (JM). Carlos III Health Institute (ISCIII). Next Generation EU funds, which finance the actions of the Recovery, Transformation and Resilience Plan. TerAv RD21/ 0017/0004 (FM) and grant PI21/00298 (FM) funded by Instituto de Salud Carlos III (ISCIII) from the Spanish Ministry of Science and Innovation, by the Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER), by Consejería de Salud y Familias (CSyF) -Junta de Andalucía - FEDER/European Cohesion Fund (FSE) for Andalucía: Grants: PECART-0031-2020 (FM, JAM). CR-P was funded by Grant PREP2022-000747 funded by MICIU/AEI /10.13039/501100011033 and by ESF+., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction

  • Araña, M.
  • Gavira,J . J.
  • Peña, E.
  • González, A.
  • Abizanda, G.
  • Cilla, M.
  • Pérez, M. M.
  • Albiasu, E.
  • Aguado, N.
  • Casado, M.
  • López, B.
  • González, S.
  • Soriano, M.
  • Moreno, C.
  • Merino, J.
  • García-Verdugo, J.
  • Díez, J.
  • Doblaré, M.
  • Pelacho, B.
  • Prosper, F.
Although transplantation of adipose-derived stem cells (ADSC) in chronic myocardial infarction (MI) models is associated with functional improvement, its therapeutic value is limited due to poor long-term cell engraftment and survival. Thus, the objective of this study was to examine whether transplantation of collagen patches seeded with ADSC could enhance cell engraftment and improve cardiac function in models of chronic MI. With that purpose, chronically infarcted Sprague–Dawley rats (n = 58) were divided into four groups and transplanted with media, collagen scaffold (CS), rat ADSC, or CS seeded with rat ADSC (CS-rADSC). Cell engraftment, histological changes, and cardiac function were assessed 4 months after transplantation. In addition, Göttingen minipigs (n = 18) were subjected to MI and then transplanted 2 months later with CS or CS seeded with autologous minipig ADSC (CS-pADSC). Functional and histological assessments were performed 3 months post-transplantation. Transplantation of CS-rADSC was associated with increased cell engraftment, significant improvement in cardiac function, myocardial remodeling, and revascularization. Moreover, transplantation of CS-pADSC in the pre-clinical swine model improved cardiac function and was associated with decreased fibrosis and increased vasculogenesis. In summary, transplantation of CS-ADSC resulted in enhanced cell engraftment and was associated with a significant improvement in cardiac function and myocardial remodeling
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center, Glomerulonefritis fibrilar: características clínico-patológicas y tratamiento en un centro terciario Español

  • Tatis Sáenz, Efraín Antonio
  • Gabaldon, Maria Alejandra
  • León-Román, Juan
  • Ramos Terrades, Natalia
  • Agraz Pamplona, Irene
  • López-Martínez, Marina
  • Núñez Delgado, Sara
  • TOAPANTA, NÉSTOR
  • Bermejo García, Sheila
  • Bestard, Oriol
  • Soler, María José
Fibrillary glomerulonephritis; Rituximab, Glomerulonefritis fibrilar; Rituximab, Glomerulonefritis fibril·lar; Rituximab, Introduction: Fibrillary glomerulonephritis (FGN) has a poor prognosis and lacks standardized treatment. In this study, we describe clinicopathological characteristics, clinical course, and management of patients with FGN at our center. Materials and methods: A retrospective cohort study of 13 patients diagnosed with FGN by positive DNAJB9 at kidney biopsy between 2019 and 2024. Demographic data, comorbidities, laboratory values, histopathological findings, and treatments were collected, Complete remission was defined as proteinuria <500 mg/g with normal renal function; partial remission as >50% reduction in proteinuria to <2000 mg/g with stable renal function; and no remission as absence of improvement, progression to end-stage kidney disease (ESKD), or death. Results: The mean age was 61.4 years, 69,2% male, median proteinuria of 2318 mg/g (38% nephrotic range) and serum creatinine 1.64 mg/dL, Histopathological findings: 29% global glomerulosclerosis. The most frequent pattern was membranoproliferative (61.6%), followed by mesangial (30.8%) and membranous in 1 patient (7.7%), Hypoalbuminemia (<3 g/dL) was associated with worse prognosis (HR 6.52, p = 0.04); proteinuria >3500 mg/g and creatinine showed non-significant trends. Immunosuppression was given in 84.6% of patients: rituximab (RTX) (61.5%), RTX + mycophenolate (7.7%), sequential RTX followed by ocrelizumab and obinutuzumab (7.7%), and corticosteroids alone (7.7%). Partial remission was achieved in 30.8%, all within the exclusive RTX group, A total of 38.4% progressed to ESKD or death. Conclusions: In our study, FGN showed poor prognosis and partial response to rituximab. FGN with hypoalbuminemia had worse outcomes. Prospective studies and larger cohorts are needed to validate these findings and optimize its management., Introducción La glomerulonefritis fibrilar (GNF) tiene un mal pronóstico y carece de tratamiento estandarizado. Materiales y métodos En este estudio analizamos las características clínicas y patológicas, evolución y manejo de 13 pacientes diagnosticados con GNF mediante biopsia renal positiva para DNAJB9 entre 2019 y 2024 en nuestro centro. Se recogieron datos demográficos, comorbilidades, valores de laboratorio, hallazgos histopatológicos y tratamientos. Se definió remisión completa como proteinuria <500 mg/g con función renal normal; remisión parcial como reducción >50% de proteinuria a <2000 mg/g con función renal estable; y sin remisión como ausencia de mejora, progresión a enfermedad renal crónica (ERC) estadio 5 o muerte. Resultados La media de edad fue 61,4 años, 69,2% hombres, con una proteinuria mediana de 2318 mg/g (38% en rango nefrótico) y creatinina sérica mediana de 1,64 mg/dL. Resultados de biopsia renal: el 29% de los glomérulos estaba esclerosado. El patrón histológico más frecuente fue el membranoproliferativo (61,6%), seguido del mesangial (30,8%) y membranosa (7,7%). La hipoalbuminemia (<3 g/dL) se asoció a peor pronóstico (HR 6,52, p = 0,04). La proteinuria >3500 mg/g y creatinina mostraron tendencias no significativas. El 84,6% recibió inmunosupresión: rituximab (RTX) (61,5%), RTX + micofenolato (7,7%), RTX seguido de ocrelizumab y obinutuzumab (7,7%), y corticoides en monoterapia (7,7%). Se consiguió remisión parcial en 30,8%, todos tratados con RTX en monoterapia. Un 38,4% progresó a ERC estadio 5 o falleció. Conclusión La GNF mostró mal pronóstico y respuesta parcial a RTX. La GNF con hipoalbuminemia presentó peor pronóstico. Se necesitan estudios prospectivos con mayores cohortes para confirmar estos hallazgos y optimizar su manejo., This study was funded by a research grant from Boehringer Ingelheim. JLR has a Río Hortega scholarship from the Carlos III Health Institute (CM23/00213). The authors are also beneficiaries of other research grants from the Carlos III Health Institute (PI21/01292, AC22/00029, INT23/00078, PI24/01510). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/31 and RD24/0004/0031) and is recognized as a consolidated group by the Agency for University and Research Aid Management of Catalonia (2021 SGR 00883).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Building wood debris piles benefits avian seed dispersers in burned and logged Mediterranean pine forests

  • Rost Bagudanch, Josep
  • Clavero Pineda, Miguel
  • Bas Lay, Josep M. (Josep Maria)
  • Pons Ferran, Pere
Salvage logging is a common practice carried out in burned forests worldwide, and intended to mitigate the economic losses caused by wildfires. Logging implies an additional disturbance occurring shortly after fire, although its ecological effects can be somewhat mitigated by leaving wood debris on site. The composition of the bird community and its capacity to provide ecosystem services such as seed dispersal of fleshy-fruited plants have been shown to be affected by postfire logging. We assessed the effects of the habitat structure resulting from different postfire management practices on the bird community, in three burned pine forests in Catalonia (western Mediterranean). For this purpose, we focused on the group of species that is responsible for seed dispersal, a process which takes place primarily during the winter in the Mediterranean basin. In addition, we assessed microhabitat selection by seed disperser birds in such environments in relation to management practices. Our results showed a significant, positive relationship between the density of wood debris piles and the abundance of seed disperser birds. Furthermore, such piles were the preferred microhabitat of these species. This reveals an important effect of forest management on seed disperser birds, which is likely to affect the dynamics of bird-dependent seed dispersal. Thus, building wood debris piles can be a useful practice for the conservation of both the species and their ecosystem services, while also being compatible with timber harvesting., This study was funded by the Spanish Ministry of Science and Innovation (CGL2005-0031/BOS and CGL2008-05506/BOS) and J.R. held a FPU grant of the Ministry of Education.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Modelling CubAm function and regulation in proximal tubular cells using iPSC-derived kidney organoids

  • Bouwens, Daphne
  • van der Velde, max
  • Salvadó-Pau, Mireia
  • Vilardell-Vilà, Jordi
  • Lopez Hellin, Joan
  • Llorens Cebrià, Carmen
  • Duran, Monica
  • Martínez Díaz, Irene
  • Meseguer, Anna
  • Ferrer Costa, Roser
  • Soler, María José
  • Cantero-Recasens, Gerard
  • Jacobs-Cacha, Conxita
Amnionless; Apolipoprotein A-I; Cubilin, Sense amnion; Apolipoproteïna A-I; Cubilina, Sin amnion; Apolipoproteína A-I; Cubilina, Idiopathic nephrotic syndrome (INS) associated to focal segmental glomeruloesclerosis or minimal change disease is characterized by the presence of heavy levels of proteinuria. Filtrated proteins are normally actively reabsorbed in the proximal tubule by the megalin-cubilin-amnionless complex, located at the apical membrane of the proximal tubule epithelial cells. Megalin has a transmembrane domain but cubilin needs to interact with amnionless to reach the cell membrane in a complex known as CubAm. While megalin has a wide variety of ligands only a few proteins are exclusively transported by binding CubAm; one of those is Apolipoprotein A-I (ApoA-I). The reabsorption of Apolipoprotein A-I (ApoA-I) seems to be impaired in INS but this aspect of INS is difficult to study due to the low expression of CubAm in cultured proximal tubular cells as well as in other in vitro tubular modelling approaches. Here we show that RPTEC/TERT-1 cells cultured in monolayer barely express cubilin and amnionless proteins. In contrast, proximal tubular cells of induced Pluripotent Stem Cells (iPSCs)-derived kidney organoids showed robust expression of CubAm. In addition, protein overload induced an increase of the number of proximal tubular cells expressing cubilin that is reversed when the stimuli is removed. Finally, exogenously added ApoA-I targets cubilin suggesting that the CubAm complex is functional in our iPSCs-derived kidney organoids. Thus, kidney organoids provide a valuable system for modelling specific aspects of INS, including the impact of protein overload on tubular cells and the CubAm-mediated endocytosis of ApoA-I, which is thought to be impaired in these conditions., CLC performed this work within the basis of her thesis at the Department de Medicina of Universitat Autònoma de Barcelona. CJC performed a short stay in the Institute of Experimental Medicine and Systems Biology and Department of Medicine 2, RWTH Aachen University Hospital (Aachen, Germany) thanks to a travel grant of the Senefro Foundation of the Spanish Society of Nephrology (2023 call). This research was funded by Fundació la Marató de TV3, grant number 202017-10 and a grant from Instituto de Salud Carlos III (PI24/01573). The authors are recipients of other research grants from Instituto de Salud Carlos III (PI21/01292, AC22/00029, INT23/00078, PI24/01510). The Nephrology and Transplantation group is part of the RICORS2040 network (RD24/0004/0031). The Nephrology and Transplantation, the Renal Physiopathology and the Clinical Biochemistry, drug delivery and therapy research groups are recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883, 2021 SGR 01600 and 021 SGR 01173, respectively).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Long-Term Impact of Peritoneal Dialysis Ultrafiltration on Cardiorenal Patients

  • Azancot Rivero, M Antonieta
  • León-Román, Juan
  • Núñez Delgado, Sara
  • Méndez Fernández, Ana Belén
  • Ramos Terrades, Natalia
  • TOAPANTA, NÉSTOR
  • Soler, María José
Cardiorenal syndrome; Diuretic resistance; Heart failure, Síndrome cardiorenal; Resistència diürètica; Insuficiència cardíaca, Síndrome cardiorrenal; Resistencia diurética; Insuficiencia cardíaca, Background: Heart failure (HF) prevalence is increasing, and its prognosis worsens in the presence of other comorbidities. Up to 70% of patients develop cardiorenal syndrome (CRS), which is associated with diuretic resistance or kidney deterioration over time. Peritoneal dialysis (PD) for ultrafiltration (PD-UF) could be a potential therapeutic option in CRS, although its long-term outcomes have not been described. Methods: Retrospective registry study of the Catalan Renal Registry on patients with PD-UF indication between 2013 and 2022. Baseline clinical characteristics and follow-up until December/2022 was studied. Results: Of the 1,874 incident patients on PD, 198 (10.6%) were PD-UF, 73.2% of the patients were male, and the mean age was 70.7 ± 9.3 years. Median estimated glomerular filtration rate (eGFR) at start was 22.6 (IQR: 14.8–32.8) mL/min×1.73 m2 and 75.0% have an eGFR above 15 mL/min×1.73 m2. Previous history of ischemic heart disease, arrhythmia, or cardiac surgery was recorded, and 57.6% of patients had ≥2 of these pathologies. The most common HF etiology was ischemic heart disease in 21.7% of patients. Median overall patient survival was 21 (IQR: 17.3–24.3) months. Technique survival at 1 year was 94.8%, and 27 patients were transferred to other renal replacement therapy (hemodialysis or kidney transplantation). In the Cox multivariate analysis, age ≥75 years (HR: 1.76 [95% CI: 1.20–2.59]), mild frailty (HR: 2.18 [95% CI: 1.17–2.59]), severe frailty (HR: 17.62 [95% CI: 1.20–55.48]), and the burden of cardiac disease (2 categories HR: 2.17 [95% CI: 1.05–4.47]; 3 categories HR: 2.26 [95% CI: 1.05–4.89]) were associated with poor overall survival. Technique survival was associated with eGFR (<30 mL/min×1.73 m2 HR: 5.64 [95% CI: 1.32–24.18]) and body mass index (<20 kg/m2 HR: 6.53 [95% CI: 1.06–40.12]) at baseline. Conclusion: PD-UF is a feasible option in patients with advanced HF and CRS. The complexity of this population increases with older age, frailty, and higher cardiac burden., M.J.S. received research funding from the Carlos III Health Institute (PI21/01292, PI24/01510). J.L.R. received a Rio Hortega grant from the Instituto de Salud Carlos III (CM23/00213). The authors are also recipients of other research grants from Instituto de Salud Carlos III (AC22/00029) and the Fundació la Marató de TV3 (202017-10, 202037-31, and 202133-30). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/0016 and RD24/0004/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy

  • Martín Agramunt, Maria
  • Llorens Cebrià, Carmen
  • León-Román, Juan
  • Pérez Beltran, Víctor
  • Saumell, Silvia
  • Torres, Irina B.
  • López González, Mercedes
  • Perurena-Prieto, Janire
  • Agraz Pamplona, Irene
  • Sellarès , Joana
  • Ramos Terrades, Natalia
  • Bestard, Oriol
  • Moreso, Francesc
  • Ariceta Iraola, Gema
  • Soler, María José
  • Hernandez-Gonzalez, Manuel
  • Jacobs-Cacha, Conxita
Biomarkers; C5 blockade; Complement system, Biomarcadors; Bloqueig C5; Sistema del complement, Biomarcadores; Bloqueo C5; Sistema del complemento, Introduction Atypical hemolytic uremic syndrome (aHUS) is a complement system (CS)–mediated ultrarare disease that manifests as thrombotic microangiopathy (TMA) with preferential small kidney vessels involvement. Transient CS activation is also observed in secondary TMA or in patients at risk of developing aHUS. There is no gold standard test to monitor disease activity; however, the ex vivo C5b-9 deposition test seems to be a good approach. Methods We assessed the C5b-9 deposition induced by serum samples of patients with aHUS (n = 8) and with TMA associated with kidney (n = 2), lung (n = 1) or hematopoietic stem cell (HSC) transplantation (HSCT, n = 2) during the acute phase of the disease or in remission. As control for transplant-associated TMA (TA-TMA), we analyzed samples of clinically stable kidney and HSC-transplanted patients without signs of TMA. In addition, we studied 1 child with genetic risk of aHUS during an acute infection. Results In the acute disease phase or in patients with disease activity despite C5 blockade, a significant increase of C5b-9 deposition was detected. In all patients with clinical response to C5 blockade but one, levels of C5b-9 deposition were within the normal range. Finally, we detected increased C5b-9 deposition levels in an asymptomatic child with genetic risk of aHUS when a concomitant otitis episode was ongoing. Conclusion The ex vivo C5b-9 deposition test is an auspicious tool to monitor CS activity in aHUS and TA-TMA. In addition, we demonstrate that the test may be useful to detect subclinical increase of CS activity, which expands the spectrum of patients that would benefit from a better CS activity assessment., This study was funded with a research grant from Alexion and a grant from the Spanish Society of Nephrology. JL-R is recipient of a Rio Hortega grant from Instituto de Salud Carlos III (CM23/00213). The authors are recipients of research grants from Instituto de Salud Carlos III (AC22/00029, PI21/01292), Fundació la Marató de TV3 (202017-10, 202037-31 and 202133-30). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883).
Docta Complutense
Publication Artículo científico (JournalArticle)

Prospects for a survey of the galactic plane with the Cherenkov Telescope Array

  • Alvarez-Crespo, N.
  • Barrio Uña, Juan Abel
  • Contreras González, José Luis
  • Dinesh, A
  • Domínguez Díaz, Alberto
  • Láinez, M
  • Larriva, A.B.
  • López Moya, Marcos
  • Martinez, O.
  • Mas-Aguilar, A.
  • Miranda, J.M.
  • Miener, Tjark
  • Moralejo Olaizola, Abelardo
  • Morcuende Parrilla, Daniel
  • Nieto Castaño, Daniel
  • Rosado Vélez, Jaime
  • Zamanillo, V.M.
Approximately one hundred sources of very-high-energy (VHE) gamma rays are known in the Milky Way, detected with a combination of targeted observations and surveys. A survey of the entire Galactic Plane in the energy range from a few tens of GeV to a few hundred TeV has been proposed as a Key Science Project for the upcoming Cherenkov Telescope Array Observatory (CTAO). This article presents the status of the studies towards the Galactic Plane Survey (GPS). We build and make publicly available a sky model that combines data from recent observations of known gamma-ray emitters with state-of-the-art physically-driven models of synthetic populations of the three main classes of established Galactic VHE sources (pulsar wind nebulae, young and interacting supernova remnants, and compact binary systems), as well as of interstellar emission from cosmic-ray interactions in the Milky Way. We also perform an optimisation of the observation strategy (pointing pattern and scheduling) based on recent estimations of the instrument performance. We use the improved sky model and observation strategy to simulate GPS data corresponding to a total observation time of 1620 hours spread over ten years. Data are then analysed using the methods and software tools under development for real data. Under our model assumptions and for the realisation considered, we show that the GPS has the potential to increase the number of known Galactic VHE emitters by almost a factor of five. This corresponds to the detection of more than two hundred pulsar wind nebulae and a few tens of supernova remnants at average integral fluxes one order of magnitude lower than in the existing sample above 1 TeV, therefore opening the possibility to perform unprecedented population studies. The GPS also has the potential to provide new VHE detections of binary systems and pulsars, to confirm the existence of a hypothetical population of gamma-ray pulsars with an additional TeV emission component, and to detect bright sources capable of accelerating particles to PeV energies (PeVatrons). Furthermore, the GPS will constitute a pathfinder for deeper follow-up observations of these source classes. Finally, we show that we can extract from GPS data an estimate of the contribution to diffuse emission from unresolved sources, and that there are good prospects of detecting interstellar emission and statistically distinguishing different scenarios. Thus, a survey of the entire Galactic plane carried out from both hemispheres with CTAO will ensure a transformational advance in our knowledge of Galactic VHE source populations and interstellar emission.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine

  • Castellsagué, Joan|||0000-0002-2579-3137
  • Gel, Bernat|||0000-0001-8878-349X
  • Fernández-Rodríguez, Juana
  • Llatjós, Roger
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Pérez-Sidelnikova, Diana
  • Garcia del Muro, Xavier|||0000-0001-5571-2847
  • Viñals, Joan Maria
  • Vidal, August|||0000-0001-5727-2099
  • Valdés-Mas, Rafael
  • Terribas, Ernest
  • López-Doriga, Adriana
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Capella, Gabriel|||0000-0002-4669-7320
  • Puente, Xose S.|||0000-0001-9525-1483
  • Serra, Eduard|||0000-0003-2895-9857
  • Villanueva Garatachea, Alberto
  • Lázaro García, Conxi|||0000-0002-7198-5906
Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas that can arise either sporadically or in association with neurofibromatosis type 1 (NF1). These aggressive malignancies confer poor survival, with no effective therapy available. We present the generation and characterization of five distinct MPNST orthoxenograft models for preclinical testing and personalized medicine. Four of the models are patient-derived tumor xenografts (PDTX), two independent MPNSTs from the same NF1 patient and two from different sporadic patients. The fifth model is an orthoxenograft derived from an NF1-related MPNST cell line. All MPNST orthoxenografts were generated by tumor implantation, or cell line injection, next to the sciatic nerve of nude mice, and were perpetuated by 7-10 mouse-to-mouse passages. The models reliably recapitulate the histopathological properties of their parental primary tumors. They also mimic distal dissemination properties in mice. Human stroma was rapidly lost after MPNST engraftment and replaced by murine stroma, which facilitated genomic tumor characterization. Compatible with an origin in a catastrophic event and subsequent genome stabilization, MPNST contained highly altered genomes that remained remarkably stable in orthoxenograft establishment and along passages. Mutational frequency and type of somatic point mutations were highly variable among the different MPNSTs modeled, but very consistent when comparing primary tumors with matched orthoxenografts generated. Unsupervised cluster analysis and principal component analysis (PCA) using an MPNST expression signature of ~1,000 genes grouped together all primary tumor-orthoxenograft pairs. Our work points to differences in the engraftment process of primary tumors compared with the engraftment of established cell lines. Following standardization and extensive characterization and validation, the orthoxenograft models were used for initial preclinical drug testing. Sorafenib (a BRAF inhibitor), in combination with doxorubicin or rapamycin, was found to be the most effective treatment for reducing MPNST growth. The development of genomically well-characterized preclinical models for MPNST allowed the evaluation of novel therapeutic strategies for personalized medicine.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Trisomy 8, a cytogenetic abnormality in Myelodysplastic Syndromes, is constitutional or not?

  • Saumell i Tutusaus, Sílvia
  • Solé Ristol, Francesc
  • Arenillas, Leonor|||0000-0002-9020-8766
  • Montoro Gómez, Maria Julia|||0000-0001-9532-7417
  • Valcárcel, David|||0000-0002-8747-078X
  • Pedro, Carme
  • Sanzo, Carmen
  • Luño, Elisa
  • Giménez, Teresa
  • Arnan, Montserrat
  • Pomares, Helena
  • Paz, Raquel de
  • Arrizabalaga, Beatriz
  • Jerez, Andrés|||0000-0002-2079-6638
  • Martínez, Ana B.
  • Sánchez-Castro, Judith
  • Rodríguez-Gambarte, Juan D.
  • Raya, José M.|||0000-0002-7202-5712
  • Ríos, Eduardo
  • Rodríguez-Rivera, María
  • Espinet i Solà, Blanca
  • Florensa Brichs, Maria Lourdes
Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarify the incidence of cT8M in myeloid neoplasms, specifically in MDS, and the diagnostic value of isolated +8 in MDS. Twenty-two MDS and 10 other myeloid neoplasms carrying +8 were studied. Trisomy 8 was determined in peripheral blood by conventional cytogenetics (CC) and on granulocytes, CD3+ lymphocytes and oral mucosa cells by fluorescence in situ hybridization (FISH). In peripheral blood CC, +8 was seen in 4/32 patients. By FISH, only one patient with chronic myelomonocytic leukemia showed +8 in all cell samples and was interpreted as a cT8M. In our series +8 was acquired in all MDS. Probably, once discarded cT8M by FISH from CD3+ lymphocytes and non-hematological cells, +8 should be considered with enough evidence to MDS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Possibilities of composting disposable diapers with municipal solid wastes

  • Colón Jordà, Joan|||0000-0003-1677-7239
  • Ruggieri, Luz
  • Sánchez, Antoni|||0000-0003-4254-8528
  • González Puig, Aina
  • Puig Ventosa, Ignasi|||0000-0002-8097-5283
The possibilities for the management of disposable diapers in municipal solid waste have been studied. An in-depth revision of literature about generation, composition and current treatment options for disposable diapers showed that the situation for these wastes is not clearly defined in developed recycling societies. As a promising technology, composting of diapers with source-separated organic fraction of municipal solid waste (OFMSW) was studied at full scale to understand the process performance and the characteristics of the compost obtained when compared with that of composting OFMSW without diapers. The experiments demonstrated that the composting process presented similar trends in terms of evolution of routine parameters (temperature, oxygen content, moisture and organic matter content) and biological activity (measured as respiration index). In relation to the quality of both composts, it can be concluded that both materials were identical in terms of stability, maturity and phytotoxicity and showed no presence of pathogenic micro-organisms. However, compost coming from OFMSW with a 3% of disposable diapers presented a slightly higher level of zinc, which can prevent the use of large amounts of diapers mixed with OFMSW.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer

  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Tonda, Raúl
  • Gausachs, Mireia
  • Trotta, Jean-Rémi
  • Castellanos, Elisabeth|||0000-0002-8133-5325
  • López-Doriga, Adriana
  • Teule, Alex|||0000-0003-0028-7200
  • Tornero, Eva
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Gel, Bernat|||0000-0001-8878-349X
  • Gut, Marta|||0000-0002-4063-7159
  • Pineda, Marta|||0000-0002-5403-5845
  • González, Sara
  • Menéndez, Mireia
  • Navarro, Matilde
  • Capella, Gabriel|||0000-0002-4669-7320
  • Gut, Ivo|||0000-0001-7219-632X
  • Serra, Eduard|||0000-0003-2895-9857
  • Brunet, Joan|||0000-0003-1945-3512
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Lázaro García, Conxi|||0000-0002-7198-5906
Next generation sequencing panels have been developed for hereditary cancer, although there is some debate about their cost-effectiveness compared to exome sequencing. The performance of two panels is compared to exome sequencing. Twenty-four patients were selected: ten with identified mutations (control set) and fourteen suspicious of hereditary cancer but with no mutation (discovery set). TruSight Cancer (94 genes) and a custom panel (122 genes) were assessed alongside exome sequencing. Eightythree genes were targeted by the two panels and exome sequencing. More than 99% of bases had a read depth of over 30x in the panels, whereas exome sequencing covered 94%. Variant calling with standard settings identified the 10 mutations in the control set, with the exception of MSH6 c.255dupC using TruSight Cancer. In the discovery set, 240 unique non-silent coding and canonic splice-site variants were identified in the panel genes, 7 of them putatively pathogenic (in ATM, BARD1, CHEK2, ERCC3, FANCL, FANCM, MSH2). The three approaches identified a similar number of variants in the shared genes. Exomes were more expensive than panels but provided additional data. In terms of cost and depth, panels are a suitable option for genetic diagnostics, although exomes also identify variants in non-targeted genes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

  • Vázquez, Iria
  • Maicas, Miren|||0000-0003-1404-5552
  • Cervera, José|||0000-0001-8252-1106
  • Agirre, Xabier|||0000-0002-6558-9560
  • Marin-Béjar, Oskar|||0000-0002-6889-6566
  • Marcotegui, Nerea
  • Vicente, Carmen
  • Lahortiga, Idoya
  • Gomez-Benito, Maria
  • Carranza, Claudia
  • Valencia, Ana
  • Brunet, Salut|||0000-0003-0491-1672
  • Lumbreras, Eva
  • Prosper, Felipe|||0000-0001-6115-8790
  • Gomez Casares, Maria Teresa|||0000-0003-0505-5126
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Calasanz, M.J|||0000-0002-0374-3008
  • Sanz, Miguel A..|||0000-0003-1489-1177
  • Sierra Gil, Jorge
  • Odero, María D.
Background: The EVI1 gene (3q26) codes for a zinc finger transcription factor with important roles in both mammalian development and leukemogenesis. Over-expression of EVI1 through either 3q26 rearrangements, MLL fusions, or other unknown mechanisms confers a poor prognosis in acute myeloid leukemia. Design and Methods: We analyzed the prevalence and prognostic impact of EVI1 over-expression in a series of 476 patients with acute myeloid leukemia, and investigated the epigenetic modifications of the EVI1 locus which could be involved in the transcriptional regulation of this gene. Results: Our data provide further evidence that EVI1 over-expression is a poor prognostic marker in acute myeloid leukemia patients less than 65 years old. Moreover, we found that patients with no basal expression of EVI1 had a better prognosis than patients with expression/over-expression (P=0.036). We also showed that cell lines with over-expression of EVI1 had no DNA methylation in the promoter region of the EVI1 locus, and had marks of active histone modifications: H3 and H4 acetylation, and trimethylation of histone H3 lysine 4. Conversely, cell lines with no expression of EVI1 have DNA hypermethylation and are marked by repressive trimethylation of histone H3 lysine 27 at the EVI1 promoter. Conclusions: Our results identify EVI1 over-expression as a poor prognostic marker in a large, independent cohort of acute myeloid leukemia patients less than 65 years old, and show that the total absence of EVI1 expression has a prognostic impact on the outcome of such patients. Furthermore, we demonstrated for the first time that an aberrant epigenetic pattern involving DNA methylation, H3 and H4 acetylation, and trimethylation of histone H3 lysine 4 and histone H3 lysine 27 might play a role in the transcriptional regulation of EVI1 in acute myeloid leukemia. This study opens new avenues for a better understanding of the regulation of EVI1 expression at a transcriptional level.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus

  • Torres, Armando|||0000-0003-1121-5173
  • Hernández, Domingo
  • Moreso, Francesc|||0000-0002-7267-3963
  • Seron, Daniel|||0000-0003-2054-653X
  • Burgos, María Dolores
  • Pallardó, Luis M.
  • Kanter, Julia
  • Díaz-Corte, Carmen
  • Rodríguez, Minerva
  • Díaz Gómez, Juan Manuel|||0000-0002-5653-6619
  • Silva, Irene|||0000-0002-2723-1031
  • Valdes, Francisco
  • Fernández-Rivera, Constantino
  • Osuna, Antonio
  • Gracia Guindo, María C.
  • Gómez Alamillo, Carlos
  • Ruiz, Juan C.
  • Marrero Miranda, Domingo
  • Pérez-Tamajón, Lourdes
  • Rodríguez, Aurelio
  • González-Rinne, Ana
  • Alvarez, Alejandra
  • Perez-Carreño, Estefanía
  • de la Vega Prieto, María José
  • Henriquez, Fernando
  • Gallego Samper, Roberto
  • Salido, Eduardo
  • Porrini, Esteban
Despite the high incidence of posttransplant diabetes mellitus (PTDM) among high-risk recipients, no studies have investigated its prevention by immunosuppression optimization. We conducted an open-label, multicenter, randomized trial testing whether a tacrolimus-based immunosuppression and rapid steroid withdrawal (SW) within 1 week (Tac-SW) or cyclosporine A (CsA) with steroid minimization (SM) (CsA-SM), decreased the incidence of PTDM compared with tacrolimus with SM (Tac-SM). All arms received basiliximab and mycophenolate mofetil. High risk was defined by age.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy

  • Medrano, Luz M.
  • Gutiérrez-Rivas, Mónica
  • Blanco, Julià|||0000-0002-2225-0217
  • García, Marcial
  • Jiménez-Sousa, María A.
  • Pacheco, Yolanda M.|||0000-0002-9451-8083
  • Montero, Marta|||0000-0002-3432-5394
  • Iribarren, José Antonio
  • Bernal, Enrique|||0000-0002-4041-0579
  • Martínez, Onofre Juan
  • Benito, José Miguel|||0000-0002-7172-049X
  • Rallón, Norma|||0000-0002-4643-247X
  • Resino, Salvador|||0000-0001-8783-0450
The mitochondrial DNA (mtDNA) seems to influence in a large number of diseases, including HIV infection. Moreover, there is a substantial inter-individual variability in the CD4+ recovery in HIV-infected patients on combination antiretroviral therapy (cART). Our study aimed to analyze the association between mtDNA haplogroups and CD4+ recovery in HIV-infected patients on cART. This is a retrospective study of 324 naïve cART patients with CD4+ < 200 cells/mm 3, who were followed-up during 24 months after initiating cART. All patients had undetectable HIV viral load during the follow-up. Besides, we included 141 healthy controls. MtDNA genotyping was performed by using Sequenom's MassARRAY platform. The primary outcome variable was the slope of CD4+ recovery. Patients were stratified into two groups by the median slope value of CD4+ (9.65 CD4+ cells/mm 3 /month). Logistic regression analyses were performed to calculate the odds of CD4+ recovery according to mtDNA haplogroups. Our study included European HIV-infected patients within the N macro-cluster. The baseline values of CD4+ T-cells were similar between groups of patients stratified by the P50th of the slope of CD4+ T-cells recovery. Patients in the low CD4+ T-cells recovery group were older (p = 0.001), but this variable was included in the multivariate models. When we analyzed the frequencies of mtDNA haplogroups, no significant differences between HIV-infected individuals and healthy controls were found. We did not find any significant association between mtDNA haplogroups and the slope of CD4+ T-cells recovery by linear regression analysis. However, Patients carrying haplogroup H had a higher odds of having a better CD4+ recovery (> 9.65 CD4+ cells/mm 3 /month) than patients without haplogroup H (p = 0.032). The adjusted logistic regression showed that patients carrying haplogroup H had a higher likelihood of achieving a CD4+ recovery > 9.65 CD4+ cells/mm 3 /month [adjusted odds ratio (aOR) = 1.75 (95% CI = 1.04; 2.95); p = 0.035]. European mitochondrial haplogroup H was associated with the improved CD4+ recovery in HIV-infected patients starting cART with CD4+ < 200 cells/mm 3.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients

  • Hernández, Domingo
  • Vázquez, Teresa
  • Alonso-Titos, Juana
  • León, Myriam
  • Caballero, Abelardo
  • Cobo, María Angeles
  • Sola, Eugenia|||0000-0002-9462-3342
  • López Jiménez, Verónica|||0000-0002-1793-7065
  • Ruiz-Esteban, Pedro
  • Cruzado, Josep María
  • Sellarés, Joana
  • Moreso, Francesc|||0000-0002-7267-3963
  • Manonelles, Anna|||0000-0003-2456-388X
  • Torio, Alberto
  • Cabello, Mercedes
  • Delgado-Burgos, Juan
  • Casas, Cristina
  • Gutiérrez, Elena
  • Jironda, Cristina
  • Kanter, Julia
  • Seron, Daniel|||0000-0003-2054-653X
  • Torres, Armando|||0000-0003-1121-5173
The impact of human leukocyte antigen (HLA)-mismatching on the early appearance of subclinical inflammation (SCI) in low-immunological-risk kidney transplant (KT) recipients is undetermined. We aimed to assess whether HLA-mismatching (A-B-C-DR-DQ) is a risk factor for early SCI. As part of a clinical trial (Clinicaltrials.gov, number NCT02284464), a total of 105 low-immunological-risk KT patients underwent a protocol biopsy on the third month post-KT. As a result, 54 presented SCI, showing a greater number of total HLA-mismatches (p = 0.008) and worse allograft function compared with the no inflammation group (48.5 ± 13.6 vs. 60 ± 23.4 mL/min; p = 0.003). Multiple logistic regression showed that the only risk factor associated with SCI was the total HLA-mismatch score (OR 1.32, 95%CI 1.06-1.64, p = 0.013) or class II HLA mismatching (OR 1.51; 95%CI 1.04-2.19, p = 0.032) after adjusting for confounder variables (recipient age, delayed graft function, transfusion prior KT, and tacrolimus levels). The ROC curve illustrated that the HLA mismatching of six antigens was the optimal value in terms of sensitivity and specificity for predicting the SCI. Finally, a significantly higher proportion of SCI was seen in patients with.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH

  • Bravo, Miren|||0000-0001-5889-9125
  • Raurell, Imma|||0000-0003-4477-7367
  • Barberá Bellés, Aurora|||0000-0002-6201-2643
  • Hide, Diana
  • Gil, Mar
  • Estrella, Federico
  • Salcedo, Maria-Teresa|||0000-0002-4822-5060
  • Augustin Recio, Salvador|||0000-0002-3515-9033
  • Genescà Ferrer, Joan|||0000-0002-0831-8422
  • Martell, María|||0000-0002-0935-0029
In non-alcoholic steatohepatitis (NASH), decreased nitric oxide and increased endothelin-1 (ET-1, also known as EDN1) released by sinusoidal endothelial cells (LSEC) induce hepatic stellate cell (HSC) contraction and contribute to portal hypertension (PH). Statins improve LSEC function, and ambrisentan is a selective endothelin-receptor-A antagonist. We aimed to analyse the combined effects of atorvastatin and ambrisentan on liver histopathology and hemodynamics, together with assessing the underlying mechanism in a rat NASH model. Diet-induced NASH rats were treated with atorvastatin (10 mg/kg/day), ambrisentan (30 mg/kg/day or 2 mg/kg/day) or a combination of both for 2 weeks. Hemodynamic parameters were registered and liver histology and serum biochemical determinations analysed. Expression of proteins were studied by immunoblotting. Conditioned media experiments were performed with LSEC. HSCs were characterized by RT-PCR, and a collagen lattice contraction assay was performed. Atorvastatin and ambrisentan act synergistically in combination to completely normalize liver hemodynamics and reverse histological NASH by 75%. Atorvastatin reversed the sinusoidal contractile phenotype, thus improving endothelial function, whereas ambrisentan prevented the contractile response in HSCs by blocking ET-1 response. Additionally, ambrisentan also increased eNOS (also known as Nos3) phosphorylation levels in LSEC, via facilitating the stimulation of endothelin-receptor-B in these cells. Furthermore, the serum alanine aminotransferase of the combined treatment group decreased to normal levels, and this group exhibited a restoration of the HSC quiescent phenotype. The combination of atorvastatin and ambrisentan remarkably improves liver histology and PH in a diet-induced NASH model. By recovering LSEC function, together with inhibiting the activation and contraction of HSC, this combined treatment may be an effective treatment for NASH patients. Summary: Combining atorvastatin with ambrisentan is safe and effective in reducing intrahepatic resistance and portal hypertension in an experimental model of NASH. This liver histology amelioration highlights a promising therapeutic strategy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Treatment of early borderline lesions in low immunological risk kidney transplant patients, a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study

  • Hernández, Domingo
  • Vázquez Sánchez, Teresa
  • Sola, Eugenia|||0000-0002-9462-3342
  • Lopez, Veronica
  • Ruiz-Esteban, Pedro
  • Caballero, Abelardo
  • Salido, Eduardo
  • León, Myriam
  • Rodriguez, Aurelio
  • Serra, Núria|||0000-0001-7926-2625
  • Rodríguez, Consuelo
  • Facundo, Carme|||0000-0003-1254-5553
  • Perello, Manel
  • Silva, Irene|||0000-0002-2723-1031
  • Marrero-Miranda, Domingo
  • Cidraque, Ignacio
  • Moreso, Francesc|||0000-0002-7267-3963
  • Guirado, Luis|||0000-0001-5119-3912
  • Seron, Daniel|||0000-0003-2054-653X
  • Torres, Armando|||0000-0003-1121-5173
Subclinical inflammation, including borderline lesions (BL), is very common (30-40%) after kidney transplantation (KT), even in low immunological risk patients, and can lead to interstitial fibrosis/tubular atrophy (IFTA) and worsening of renal function with graft loss. Few controlled studies have analyzed the therapeutic benefit of treating these BL on renal function and graft histology. Furthermore, these studies have only used bolus steroids, which may be insufficient to slow the progression of these lesions. Klotho, a transmembrane protein produced mainly in the kidney with antifibrotic properties, plays a crucial role in the senescence-inflammation binomial of kidney tissue. Systemic and local inflammation decrease renal tissue expression and soluble levels of α-klotho. It is therefore important to determine whether treatment of BL prevents a decrease in α-klotho levels, progression of IFTA, and loss of kidney function. The TRAINING study will randomize 80 patients with low immunological risk who will receive their first KT. The aim of the study is to determine whether the treatment of early BL (3rd month post-KT) with polyclonal rabbit antithymocyte globulin (Grafalon®) (6 mg/kg/day) prevents or decreases the progression of IFTA and the worsening of graft function compared to conventional therapy after two years post-KT, as well as to analyze whether treatment of BL with Grafalon® can modify the expression and levels of klotho, as well as the pro-inflammatory cytokines that regulate its expression. This phase IV investigator-driven, randomized, placebo-controlled clinical trial will examine the efficacy and safety of Grafalon® treatment in low-immunological-risk KT patients with early BL. : NCT04936282. Registered June 23, 2021, . Protocol Version 2 of 21 January 2022. Sponsor: Canary Isles Institute for Health Research Foundation, Canary Isles (FIISC). mgomez@fciisc.org.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy, a review from the ESGMYC study group

  • Melkie, Solomon Tibebu|||0000-0001-6252-0712
  • Arias, Lilibeth|||0000-0002-2469-8832
  • Farroni, Chiara|||0000-0002-2425-9936
  • Jankovic Makek, Mateja|||0000-0002-0171-764X
  • Goletti, Delia|||0000-0001-8360-4376
  • Vilaplana, Cristina|||0000-0002-2808-7270
Tuberculosis (TB) is still responsible for the deaths of >1 million people yearly worldwide, and therefore its correct diagnosis is one of the key components of any TB eradication programme. However, current TB diagnostic tests have many limitations, and improved diagnostic accuracy is urgently needed. To improve the diagnostic performance of traditional serology, a combination of different Mycobacterium tuberculosis (MTB) antigens and different antibody isotypes has been suggested, with some showing promising performance for the diagnosis of active TB. Given the incomplete protection conferred by bacille Calmette-Guérin (BCG) vaccination against adult pulmonary TB, efforts to discover novel TB vaccines are ongoing. Efficacy studies from advanced TB vaccines designed to stimulate cell-mediated immunity failed to show protection, suggesting that they may not be sufficient and warranting the need for other types of immunity. The role of antibodies as tools for TB therapy, TB diagnosis and TB vaccine design is discussed. Finally, we propose that the inclusion of antibody-based TB vaccines in current clinical trials may be advisable to improve protection. Despite being controversial, antibodies could play a role in the diagnosis of active TB, LTBI and treatment response monitoring. Antibodies could also help when administered as passive transfer and in the protection generated by new TB vaccine candidates.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country, a case series analysis

  • Roure, Silvia|||0000-0002-7982-0890
  • Vallès, Xavier|||0000-0002-4445-1490
  • Sopena, Nieves|||0000-0001-6382-9500
  • Benítez Díaz, Rosa María|||0000-0001-6972-6094
  • Reynaga, Esteban|||0000-0002-4069-6087
  • Bracke Manzanares, Carmen|||0000-0002-0306-8321
  • Loste, Cora
  • Mateu, Lourdes|||0000-0001-7223-7611
  • Antuori Torres, Adrián|||0000-0002-2782-3125
  • Baena, Tania
  • Portela, Germán
  • Llussà, Judith|||0000-0002-6886-6084
  • Flamarich, Clara|||0000-0002-2784-6108
  • Soldevila Langa, Laura|||0000-0002-3324-0225
  • Tenesa Bordas, Montserrat|||0000-0002-9729-090X
  • Pérez, Ricard
  • Plasencia, Elsa
  • Bechini Bernad, Jordi|||0000-0001-7735-0621
  • Pedro Botet, Maria Luisa|||0000-0001-7252-3191
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
Disseminated tuberculosis is frequently associated with delayed diagnosis and a poorer prognosis. To describe case series of disseminated TB and diagnosis delay in a low TB burden country during the COVID-19 period. We consecutively included all patients with of disseminated TB reported from 2019 to 2021 in the reference hospital of the Northern Crown of the Metropolitan Area of Barcelona. We collected socio-demographic information, clinical, laboratory and radiological findings. We included all 30 patients reported during the study period-5, 9, and 16 in 2019, 2020, and 2021 respectively-20 (66.7%) of whom were male and whose mean age was 41 years. Twenty-five (83.3%) were of non-EU origin. The most frequent system involvement was central nervous system (N = 8; 26.7%) followed by visceral (N = 7; 23.3%), gastro-intestinal (N = 6, 20.0%), musculoskeletal (N = 5; 16.7%), and pulmonary (N = 4; 13.3%). Hypoalbuminemia and anemia were highly prevalent (72 and 77%). The median of diagnostic delay was 6.5 months (IQR 1.8-30), which was higher among women (36.0 vs. 3.5 months; p = 0.002). Central nervous system involvement and pulmonary involvement were associated with diagnostic delay among women. We recorded 24 cured patients, two deaths, three patients with post-treatment sequelae, and one lost-to-follow up. We observed a clustering effect of patients in low-income neighborhoods (p < 0.001). There was a substantial delay in the diagnosis of disseminated TB in our study region, which might impacted the prognosis with women affected more negatively. Our results suggest that an increase in the occurrence of disseminated TB set in motion by diagnosis delay may have been a secondary effect of the COVID-19 pandemic.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure, A Substudy of the Myocardial-IRON Trial

  • del Canto, Irene
  • Santas, Enrique
  • Cardells, Ingrid
  • Miñana, Gema|||0000-0001-8777-2588
  • Palau, Patricia|||0000-0001-5040-0924
  • Llàcer, Pau
  • Facila Rubio, Lorenzo|||0000-0003-1402-4364
  • López-Vilella, Raquel
  • Almenar Bonet, Luis|||0000-0002-7710-361X
  • Bodi, Vicente|||0000-0001-6425-5828
  • López-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Sanchis, Juan|||0000-0003-0797-8709
  • Moratal, David|||0000-0002-2825-3646
  • Maceira, Alicia M.|||0000-0001-5486-4232
  • De la Espriella, Rafael|||0000-0002-8720-3999
  • Chorro, Francisco J.
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Núñez, Julio|||0000-0003-1672-7119
The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial-IRON trial showed short-term cardiac magnetic resonance (CMR) changes suggesting myocardial iron repletion following administration of FCM but failed to find a significant increase in left ventricular ejection fraction in the whole sample. Conversely, the strain assessment could evaluate more specifically subtle changes in contractility. In this subanalysis, we aimed to evaluate the effect of FCM on the short-term left and right ventricular CMR feature tracking derived strain. This is a post hoc subanalysis of the double-blind, placebo-controlled, randomized clinical trial that enrolled 53 ambulatory patients with heart failure and left ventricular ejection fraction <50%, and iron deficiency [Myocardial-IRON trial (NCT03398681)]. Three-dimensional left and 2-dimensional right ventricular CMR tracking strain (longitudinal, circumferential, and radial) changes were evaluated before, 7 and 30 days after randomization using linear mixed-effect analysis. The median (interquartile range) age of the sample was 73 years (65-78), and 40 (75.5%) were men. At baseline, there were no significant differences in CMR feature tracking strain parameters across both treatment arms. At 7 days, the only global 3-dimensional left ventricular circumferential strain was significantly higher in the FCM treatment-arm (difference: -1.6%, P =0.001). At 30 days, and compared with placebo, global 3-dimensional left ventricular strain parameters significantly improved in those allocated to FCM treatment-arm [longitudinal (difference: -2.3%, P <0.001), circumferential (difference: -2.5%, P <0.001), and radial (difference: 4.2%, P =0.002)]. Likewise, significant improvements in global right ventricular strain parameters were found in the active arm at 30 days (longitudinal [difference: -3.3%, P =0.010], circumferential [difference: -4.5%, P <0.001], and radial [difference: 4.5%, P =0.027]). In patients with stable heart failure, left ventricular ejection fraction <50%, and iron deficiency, treatment with FCM was associated with short-term improvements in left and right ventricular function assessed by CMR feature tracking derived strain parameters. URL: ; Unique identifier: NCT03398681.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive constitutional genetic and epigenetic characterization of lynch-like individuals

  • Dámaso, Estela|||0000-0002-9650-7791
  • González-Acosta, Maribel|||0000-0002-2468-3876
  • Vargas-Parra, Gardenia|||0000-0003-1378-736X
  • Navarro, Matilde
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Tuset, Noemí
  • Thompson, Bryony A.
  • Marín, Fátima
  • Fernández, Anna
  • Gómez, Carolina
  • Velasco, Àngela
  • Solanes, Ares
  • Iglesias Casals, Sílvia
  • Urgel, Gisela
  • López, Consol
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Campos, Olga
  • Santacana, Maria|||0000-0003-1975-2598
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Valle, Laura|||0000-0003-0371-0844
  • Brunet, Joan|||0000-0003-1945-3512
  • Pineda, Marta|||0000-0002-5403-5845
  • Capella, Gabriel|||0000-0002-4669-7320
The causal mechanism for cancer predisposition in Lynch-like syndrome (LLS) remains unknown. Our aim was to elucidate the constitutional basis of mismatch repair (MMR) deficiency in LLS patients throughout a comprehensive (epi)genetic analysis. One hundred and fifteen LLS patients harboring MMR-deficient tumors and no germline MMR mutations were included. Mutational analysis of 26 colorectal cancer (CRC)-associated genes was performed. Pathogenicity of MMR variants was assessed by splicing and multifactorial likelihood analyses. Genome-wide methylome analysis was performed by the Infinium Human Methylation 450K Bead Chip. The multigene panel analysis revealed the presence of two MMR gene truncating mutations not previously found. Of a total of 15 additional MMR variants identified, five-present in 6 unrelated individuals-were reclassified as pathogenic. In addition, 13 predicted deleterious variants in other CRC-predisposing genes were found in 12 probands. Methylome analysis detected one constitutional MLH1 epimutation, but no additional differentially methylated regions were identified in LLS compared to LS patients or cancer-free individuals. In conclusion, the use of an ad-hoc designed gene panel combined with pathogenicity assessment of variants allowed the identification of deleterious MMR mutations as well as new LLS candidate causal genes. Constitutional epimutations in non-LS-associated genes are not responsible for LLS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A longitudinal prospective study of active tuberculosis in a Western Europe setting, insights and findings

  • Romero-Tamarit, Arantxa
  • Vallès, Xavier|||0000-0002-4445-1490
  • Munar-García, María
  • Espinosa-Pereiro, Juan|||0000-0002-7238-8337
  • Saborit, Núria
  • Tórtola Fernández, María Teresa|||0000-0002-9188-298X
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Roure, Silvia|||0000-0002-7982-0890
  • Antuori Torres, Adrián|||0000-0002-2782-3125
  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Espiau, María|||0000-0001-9697-7649
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez, Ma. Ángeles
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Molina Romero, Israel|||0000-0001-6642-7515
  • Casas, Xavier|||0000-0002-3892-9697
  • Domínguez-Álvarez, Marisol
  • Jové, Neus
  • Gogichadze, Nino|||0000-0001-7014-1608
  • Fonseca, Kaori L.|||0000-0002-7048-9740
  • Arias, Lilibeth|||0000-0002-2469-8832
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Sánchez Montalvá, Adrián|||0000-0002-2194-5447
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
This study investigates the potential of inflammatory parameters (IP), symptoms, and patient-related outcome measurements as biomarkers of severity and their ability to predict tuberculosis (TB) evolution. People with TB were included prospectively in the Stage-TB study conducted at five clinical sites in Barcelona (Spain) between April 2018 and December 2021. Data on demographics, epidemiology, clinical features, microbiology, and Sanit George Respiratory Questionnaire (SGRQ) and Kessler-10 as Health-Related Quality of Life (HRQoL) were collected at three time points during treatment. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), neutrophil/lymphocyte, and monocyte/lymphocyte ratios (NLR and MLR), complement factors C3, C4, and cH50, clinical and microbiological data, and HRQoL questionnaires were assessed at baseline, 2 months, and 6 months. Their ability to predict sputum culture conversion (SCC) and symptom presence after 2 months of treatment was also analysed. The study included 81 adults and 13 children with TB. The CRP, ESR, NLR, and MLR values, as well as the presence of symptoms, decreased significantly over time in both groups. Higher IP levels at baseline were associated with greater bacillary load and persistent symptoms. Clinical severity at baseline predicted a delayed SCC. Kessler-10 improved during follow-up, but self-reported lung impairment (SGRQ) persisted in all individuals after 6 months. IP levels may indicate disease severity, and sustained high levels are linked to lower treatment efficacy. Baseline clinical severity is the best predictor of SCC. Implementing health strategies to evaluate lung function and mental health throughout the disease process may be crucial for individuals with TB. The online version contains supplementary material available at 10.1007/s15010-024-02184-2.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy

  • Martín Agramunt, Maria
  • Llorens Cebrià, Carmen
  • León-Román, Juan
  • Pérez Beltran, Víctor
  • Saumell, Silvia
  • Torres, Irina B.
  • López González, Mercedes
  • Perurena-Prieto, Janire
  • Agraz Pamplona, Irene
  • Sellarès , Joana
  • Ramos Terrades, Natalia
  • Bestard, Oriol
  • Moreso, Francesc
  • Ariceta Iraola, Gema
  • Soler, María José
  • Hernandez-Gonzalez, Manuel
  • Jacobs-Cacha, Conxita
Biomarkers; C5 blockade; Complement system, Biomarcadors; Bloqueig C5; Sistema del complement, Biomarcadores; Bloqueo C5; Sistema del complemento, Introduction Atypical hemolytic uremic syndrome (aHUS) is a complement system (CS)–mediated ultrarare disease that manifests as thrombotic microangiopathy (TMA) with preferential small kidney vessels involvement. Transient CS activation is also observed in secondary TMA or in patients at risk of developing aHUS. There is no gold standard test to monitor disease activity; however, the ex vivo C5b-9 deposition test seems to be a good approach. Methods We assessed the C5b-9 deposition induced by serum samples of patients with aHUS (n = 8) and with TMA associated with kidney (n = 2), lung (n = 1) or hematopoietic stem cell (HSC) transplantation (HSCT, n = 2) during the acute phase of the disease or in remission. As control for transplant-associated TMA (TA-TMA), we analyzed samples of clinically stable kidney and HSC-transplanted patients without signs of TMA. In addition, we studied 1 child with genetic risk of aHUS during an acute infection. Results In the acute disease phase or in patients with disease activity despite C5 blockade, a significant increase of C5b-9 deposition was detected. In all patients with clinical response to C5 blockade but one, levels of C5b-9 deposition were within the normal range. Finally, we detected increased C5b-9 deposition levels in an asymptomatic child with genetic risk of aHUS when a concomitant otitis episode was ongoing. Conclusion The ex vivo C5b-9 deposition test is an auspicious tool to monitor CS activity in aHUS and TA-TMA. In addition, we demonstrate that the test may be useful to detect subclinical increase of CS activity, which expands the spectrum of patients that would benefit from a better CS activity assessment., This study was funded with a research grant from Alexion and a grant from the Spanish Society of Nephrology. JL-R is recipient of a Rio Hortega grant from Instituto de Salud Carlos III (CM23/00213). The authors are recipients of research grants from Instituto de Salud Carlos III (AC22/00029, PI21/01292), Fundació la Marató de TV3 (202017-10, 202037-31 and 202133-30). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Long-Term Impact of Peritoneal Dialysis Ultrafiltration on Cardiorenal Patients

  • Azancot Rivero, M Antonieta
  • León-Román, Juan
  • Núñez Delgado, Sara
  • Méndez Fernández, Ana Belén
  • Ramos Terrades, Natalia
  • TOAPANTA, NÉSTOR
  • Soler, María José
Cardiorenal syndrome; Diuretic resistance; Heart failure, Síndrome cardiorenal; Resistència diürètica; Insuficiència cardíaca, Síndrome cardiorrenal; Resistencia diurética; Insuficiencia cardíaca, Background: Heart failure (HF) prevalence is increasing, and its prognosis worsens in the presence of other comorbidities. Up to 70% of patients develop cardiorenal syndrome (CRS), which is associated with diuretic resistance or kidney deterioration over time. Peritoneal dialysis (PD) for ultrafiltration (PD-UF) could be a potential therapeutic option in CRS, although its long-term outcomes have not been described. Methods: Retrospective registry study of the Catalan Renal Registry on patients with PD-UF indication between 2013 and 2022. Baseline clinical characteristics and follow-up until December/2022 was studied. Results: Of the 1,874 incident patients on PD, 198 (10.6%) were PD-UF, 73.2% of the patients were male, and the mean age was 70.7 ± 9.3 years. Median estimated glomerular filtration rate (eGFR) at start was 22.6 (IQR: 14.8–32.8) mL/min×1.73 m2 and 75.0% have an eGFR above 15 mL/min×1.73 m2. Previous history of ischemic heart disease, arrhythmia, or cardiac surgery was recorded, and 57.6% of patients had ≥2 of these pathologies. The most common HF etiology was ischemic heart disease in 21.7% of patients. Median overall patient survival was 21 (IQR: 17.3–24.3) months. Technique survival at 1 year was 94.8%, and 27 patients were transferred to other renal replacement therapy (hemodialysis or kidney transplantation). In the Cox multivariate analysis, age ≥75 years (HR: 1.76 [95% CI: 1.20–2.59]), mild frailty (HR: 2.18 [95% CI: 1.17–2.59]), severe frailty (HR: 17.62 [95% CI: 1.20–55.48]), and the burden of cardiac disease (2 categories HR: 2.17 [95% CI: 1.05–4.47]; 3 categories HR: 2.26 [95% CI: 1.05–4.89]) were associated with poor overall survival. Technique survival was associated with eGFR (<30 mL/min×1.73 m2 HR: 5.64 [95% CI: 1.32–24.18]) and body mass index (<20 kg/m2 HR: 6.53 [95% CI: 1.06–40.12]) at baseline. Conclusion: PD-UF is a feasible option in patients with advanced HF and CRS. The complexity of this population increases with older age, frailty, and higher cardiac burden., M.J.S. received research funding from the Carlos III Health Institute (PI21/01292, PI24/01510). J.L.R. received a Rio Hortega grant from the Instituto de Salud Carlos III (CM23/00213). The authors are also recipients of other research grants from Instituto de Salud Carlos III (AC22/00029) and the Fundació la Marató de TV3 (202017-10, 202037-31, and 202133-30). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/0016 and RD24/0004/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Modelling CubAm function and regulation in proximal tubular cells using iPSC-derived kidney organoids

  • Bouwens, Daphne
  • van der Velde, max
  • Salvadó-Pau, Mireia
  • Vilardell-Vilà, Jordi
  • Lopez Hellin, Joan
  • Llorens Cebrià, Carmen
  • Duran, Monica
  • Martínez Díaz, Irene
  • Meseguer, Anna
  • Ferrer Costa, Roser
  • Soler, María José
  • Cantero-Recasens, Gerard
  • Jacobs-Cacha, Conxita
Amnionless; Apolipoprotein A-I; Cubilin, Sense amnion; Apolipoproteïna A-I; Cubilina, Sin amnion; Apolipoproteína A-I; Cubilina, Idiopathic nephrotic syndrome (INS) associated to focal segmental glomeruloesclerosis or minimal change disease is characterized by the presence of heavy levels of proteinuria. Filtrated proteins are normally actively reabsorbed in the proximal tubule by the megalin-cubilin-amnionless complex, located at the apical membrane of the proximal tubule epithelial cells. Megalin has a transmembrane domain but cubilin needs to interact with amnionless to reach the cell membrane in a complex known as CubAm. While megalin has a wide variety of ligands only a few proteins are exclusively transported by binding CubAm; one of those is Apolipoprotein A-I (ApoA-I). The reabsorption of Apolipoprotein A-I (ApoA-I) seems to be impaired in INS but this aspect of INS is difficult to study due to the low expression of CubAm in cultured proximal tubular cells as well as in other in vitro tubular modelling approaches. Here we show that RPTEC/TERT-1 cells cultured in monolayer barely express cubilin and amnionless proteins. In contrast, proximal tubular cells of induced Pluripotent Stem Cells (iPSCs)-derived kidney organoids showed robust expression of CubAm. In addition, protein overload induced an increase of the number of proximal tubular cells expressing cubilin that is reversed when the stimuli is removed. Finally, exogenously added ApoA-I targets cubilin suggesting that the CubAm complex is functional in our iPSCs-derived kidney organoids. Thus, kidney organoids provide a valuable system for modelling specific aspects of INS, including the impact of protein overload on tubular cells and the CubAm-mediated endocytosis of ApoA-I, which is thought to be impaired in these conditions., CLC performed this work within the basis of her thesis at the Department de Medicina of Universitat Autònoma de Barcelona. CJC performed a short stay in the Institute of Experimental Medicine and Systems Biology and Department of Medicine 2, RWTH Aachen University Hospital (Aachen, Germany) thanks to a travel grant of the Senefro Foundation of the Spanish Society of Nephrology (2023 call). This research was funded by Fundació la Marató de TV3, grant number 202017-10 and a grant from Instituto de Salud Carlos III (PI24/01573). The authors are recipients of other research grants from Instituto de Salud Carlos III (PI21/01292, AC22/00029, INT23/00078, PI24/01510). The Nephrology and Transplantation group is part of the RICORS2040 network (RD24/0004/0031). The Nephrology and Transplantation, the Renal Physiopathology and the Clinical Biochemistry, drug delivery and therapy research groups are recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883, 2021 SGR 01600 and 021 SGR 01173, respectively).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center, Glomerulonefritis fibrilar: características clínico-patológicas y tratamiento en un centro terciario Español

  • Tatis Sáenz, Efraín Antonio
  • Gabaldon, Maria Alejandra
  • León-Román, Juan
  • Ramos Terrades, Natalia
  • Agraz Pamplona, Irene
  • López-Martínez, Marina
  • Núñez Delgado, Sara
  • TOAPANTA, NÉSTOR
  • Bermejo García, Sheila
  • Bestard, Oriol
  • Soler, María José
Fibrillary glomerulonephritis; Rituximab, Glomerulonefritis fibrilar; Rituximab, Glomerulonefritis fibril·lar; Rituximab, Introduction: Fibrillary glomerulonephritis (FGN) has a poor prognosis and lacks standardized treatment. In this study, we describe clinicopathological characteristics, clinical course, and management of patients with FGN at our center. Materials and methods: A retrospective cohort study of 13 patients diagnosed with FGN by positive DNAJB9 at kidney biopsy between 2019 and 2024. Demographic data, comorbidities, laboratory values, histopathological findings, and treatments were collected, Complete remission was defined as proteinuria <500 mg/g with normal renal function; partial remission as >50% reduction in proteinuria to <2000 mg/g with stable renal function; and no remission as absence of improvement, progression to end-stage kidney disease (ESKD), or death. Results: The mean age was 61.4 years, 69,2% male, median proteinuria of 2318 mg/g (38% nephrotic range) and serum creatinine 1.64 mg/dL, Histopathological findings: 29% global glomerulosclerosis. The most frequent pattern was membranoproliferative (61.6%), followed by mesangial (30.8%) and membranous in 1 patient (7.7%), Hypoalbuminemia (<3 g/dL) was associated with worse prognosis (HR 6.52, p = 0.04); proteinuria >3500 mg/g and creatinine showed non-significant trends. Immunosuppression was given in 84.6% of patients: rituximab (RTX) (61.5%), RTX + mycophenolate (7.7%), sequential RTX followed by ocrelizumab and obinutuzumab (7.7%), and corticosteroids alone (7.7%). Partial remission was achieved in 30.8%, all within the exclusive RTX group, A total of 38.4% progressed to ESKD or death. Conclusions: In our study, FGN showed poor prognosis and partial response to rituximab. FGN with hypoalbuminemia had worse outcomes. Prospective studies and larger cohorts are needed to validate these findings and optimize its management., Introducción La glomerulonefritis fibrilar (GNF) tiene un mal pronóstico y carece de tratamiento estandarizado. Materiales y métodos En este estudio analizamos las características clínicas y patológicas, evolución y manejo de 13 pacientes diagnosticados con GNF mediante biopsia renal positiva para DNAJB9 entre 2019 y 2024 en nuestro centro. Se recogieron datos demográficos, comorbilidades, valores de laboratorio, hallazgos histopatológicos y tratamientos. Se definió remisión completa como proteinuria <500 mg/g con función renal normal; remisión parcial como reducción >50% de proteinuria a <2000 mg/g con función renal estable; y sin remisión como ausencia de mejora, progresión a enfermedad renal crónica (ERC) estadio 5 o muerte. Resultados La media de edad fue 61,4 años, 69,2% hombres, con una proteinuria mediana de 2318 mg/g (38% en rango nefrótico) y creatinina sérica mediana de 1,64 mg/dL. Resultados de biopsia renal: el 29% de los glomérulos estaba esclerosado. El patrón histológico más frecuente fue el membranoproliferativo (61,6%), seguido del mesangial (30,8%) y membranosa (7,7%). La hipoalbuminemia (<3 g/dL) se asoció a peor pronóstico (HR 6,52, p = 0,04). La proteinuria >3500 mg/g y creatinina mostraron tendencias no significativas. El 84,6% recibió inmunosupresión: rituximab (RTX) (61,5%), RTX + micofenolato (7,7%), RTX seguido de ocrelizumab y obinutuzumab (7,7%), y corticoides en monoterapia (7,7%). Se consiguió remisión parcial en 30,8%, todos tratados con RTX en monoterapia. Un 38,4% progresó a ERC estadio 5 o falleció. Conclusión La GNF mostró mal pronóstico y respuesta parcial a RTX. La GNF con hipoalbuminemia presentó peor pronóstico. Se necesitan estudios prospectivos con mayores cohortes para confirmar estos hallazgos y optimizar su manejo., This study was funded by a research grant from Boehringer Ingelheim. JLR has a Río Hortega scholarship from the Carlos III Health Institute (CM23/00213). The authors are also beneficiaries of other research grants from the Carlos III Health Institute (PI21/01292, AC22/00029, INT23/00078, PI24/01510). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/31 and RD24/0004/0031) and is recognized as a consolidated group by the Agency for University and Research Aid Management of Catalonia (2021 SGR 00883).